Review



3142001b  (fluidigm)


Bioz Verified Symbol fluidigm is a verified supplier
Bioz Manufacturer Symbol fluidigm manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    fluidigm 3142001b
    3142001b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3142001b/product/fluidigm
    Average 93 stars, based on 26 article reviews
    3142001b - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    93
    fluidigm 3142001b
    3142001b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3142001b/product/fluidigm
    Average 93 stars, based on 1 article reviews
    3142001b - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    fluidigm cd19
    a , b , Defective B cell maturation in the BM of individuals with CBL -LOH. Flow cytometry staining of cryopreserved BM mononuclear cells of HDs and participants P1, P2 and P3 with CBL -LOH. a , Representative flow staining of CD20 versus CD10 expression levels on CD34 − <t>CD19</t> + cells in BM samples. b , Quantification of these subsets for HDs ( n = 8), individuals with CBL -LOH ( n = 3) and individuals with PIK3CD GOF ( n = 3). The line shows the mean of the data points. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; * P < 0.05. c , d , In vitro differentiation of control AAVS1 -edited and CBL -edited CD34 + HSPCs toward B cell identity. c , Flow cytometry staining for CD10 and CD20 among CD19 + cells in differentiation cultures after 3 weeks of coculture. d , Quantification of B cell ‘subsets’ based on flow cytometry marker expression (pre-BI, CD10 + CD20 − ; pre-BII, CD10 + CD20 + ; immature B, CD10 + CD20 ++ ; mature B, CD10 − CD20 ++ ) in this culture in control and two CBL -edited reactions. The lines show the means of three biological replicates, except for AAVS1 single guide RNA (sgRNA) 1, where two replicates are shown. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; ** P < 0.005. e , Transcriptional overlap between CBL -edited and PI3K GOF HSPC-derived B cell progenitors. Gene set enrichment analysis for PI3K GOF gene signatures in CBL Ub LOF samples is shown; NES, normalized enrichment score. No correction for multiple testing was performed for the two binomial tests. f , Quantitative genotyping by amplicon sequencing of B cell subsets and monocytes in individuals with CBL -LOH and HDs, as well as parents of P1–P3; HDs ( n = 3), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. g , CD38 staining intensity of primary B cell subsets of pediatric individuals with CBL -LOH compared with age-matched HDs; HDs ( n = 9), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. The statistical significance of differences was assessed by multiple two-sided Mann–Whitney tests, with correction for multiple testing; * P < 0.05. h , Rate of apoptosis following stimulation with daratumumab of CD19 + cells from in vitro differentiation cultures of control and CBL -edited HSPCs. Data show the mean of three technical replicates. The experiment is representative of three biological replicates. i , Rate of apoptosis following stimulation with daratumumab of control and CBL Y371C KI REH cells. Each dot represents one biological replicate; n = 7. The statistical significance of differences was assessed using multiple paired, two-sided t- tests, with correction for multiple testing. j , Western blot of control and CBL Y371C KI REH cells following stimulation with monoclonal anti-CD38 (daratumumab) for the indicated times (min).
    Cd19, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19/product/fluidigm
    Average 93 stars, based on 1 article reviews
    cd19 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    fluidigm hib19
    a , b , Defective B cell maturation in the BM of individuals with CBL -LOH. Flow cytometry staining of cryopreserved BM mononuclear cells of HDs and participants P1, P2 and P3 with CBL -LOH. a , Representative flow staining of CD20 versus CD10 expression levels on CD34 − <t>CD19</t> + cells in BM samples. b , Quantification of these subsets for HDs ( n = 8), individuals with CBL -LOH ( n = 3) and individuals with PIK3CD GOF ( n = 3). The line shows the mean of the data points. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; * P < 0.05. c , d , In vitro differentiation of control AAVS1 -edited and CBL -edited CD34 + HSPCs toward B cell identity. c , Flow cytometry staining for CD10 and CD20 among CD19 + cells in differentiation cultures after 3 weeks of coculture. d , Quantification of B cell ‘subsets’ based on flow cytometry marker expression (pre-BI, CD10 + CD20 − ; pre-BII, CD10 + CD20 + ; immature B, CD10 + CD20 ++ ; mature B, CD10 − CD20 ++ ) in this culture in control and two CBL -edited reactions. The lines show the means of three biological replicates, except for AAVS1 single guide RNA (sgRNA) 1, where two replicates are shown. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; ** P < 0.005. e , Transcriptional overlap between CBL -edited and PI3K GOF HSPC-derived B cell progenitors. Gene set enrichment analysis for PI3K GOF gene signatures in CBL Ub LOF samples is shown; NES, normalized enrichment score. No correction for multiple testing was performed for the two binomial tests. f , Quantitative genotyping by amplicon sequencing of B cell subsets and monocytes in individuals with CBL -LOH and HDs, as well as parents of P1–P3; HDs ( n = 3), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. g , CD38 staining intensity of primary B cell subsets of pediatric individuals with CBL -LOH compared with age-matched HDs; HDs ( n = 9), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. The statistical significance of differences was assessed by multiple two-sided Mann–Whitney tests, with correction for multiple testing; * P < 0.05. h , Rate of apoptosis following stimulation with daratumumab of CD19 + cells from in vitro differentiation cultures of control and CBL -edited HSPCs. Data show the mean of three technical replicates. The experiment is representative of three biological replicates. i , Rate of apoptosis following stimulation with daratumumab of control and CBL Y371C KI REH cells. Each dot represents one biological replicate; n = 7. The statistical significance of differences was assessed using multiple paired, two-sided t- tests, with correction for multiple testing. j , Western blot of control and CBL Y371C KI REH cells following stimulation with monoclonal anti-CD38 (daratumumab) for the indicated times (min).
    Hib19, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hib19/product/fluidigm
    Average 93 stars, based on 1 article reviews
    hib19 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    fluidigm mouse monoclonal cd19
    a , b , Defective B cell maturation in the BM of individuals with CBL -LOH. Flow cytometry staining of cryopreserved BM mononuclear cells of HDs and participants P1, P2 and P3 with CBL -LOH. a , Representative flow staining of CD20 versus CD10 expression levels on CD34 − <t>CD19</t> + cells in BM samples. b , Quantification of these subsets for HDs ( n = 8), individuals with CBL -LOH ( n = 3) and individuals with PIK3CD GOF ( n = 3). The line shows the mean of the data points. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; * P < 0.05. c , d , In vitro differentiation of control AAVS1 -edited and CBL -edited CD34 + HSPCs toward B cell identity. c , Flow cytometry staining for CD10 and CD20 among CD19 + cells in differentiation cultures after 3 weeks of coculture. d , Quantification of B cell ‘subsets’ based on flow cytometry marker expression (pre-BI, CD10 + CD20 − ; pre-BII, CD10 + CD20 + ; immature B, CD10 + CD20 ++ ; mature B, CD10 − CD20 ++ ) in this culture in control and two CBL -edited reactions. The lines show the means of three biological replicates, except for AAVS1 single guide RNA (sgRNA) 1, where two replicates are shown. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; ** P < 0.005. e , Transcriptional overlap between CBL -edited and PI3K GOF HSPC-derived B cell progenitors. Gene set enrichment analysis for PI3K GOF gene signatures in CBL Ub LOF samples is shown; NES, normalized enrichment score. No correction for multiple testing was performed for the two binomial tests. f , Quantitative genotyping by amplicon sequencing of B cell subsets and monocytes in individuals with CBL -LOH and HDs, as well as parents of P1–P3; HDs ( n = 3), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. g , CD38 staining intensity of primary B cell subsets of pediatric individuals with CBL -LOH compared with age-matched HDs; HDs ( n = 9), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. The statistical significance of differences was assessed by multiple two-sided Mann–Whitney tests, with correction for multiple testing; * P < 0.05. h , Rate of apoptosis following stimulation with daratumumab of CD19 + cells from in vitro differentiation cultures of control and CBL -edited HSPCs. Data show the mean of three technical replicates. The experiment is representative of three biological replicates. i , Rate of apoptosis following stimulation with daratumumab of control and CBL Y371C KI REH cells. Each dot represents one biological replicate; n = 7. The statistical significance of differences was assessed using multiple paired, two-sided t- tests, with correction for multiple testing. j , Western blot of control and CBL Y371C KI REH cells following stimulation with monoclonal anti-CD38 (daratumumab) for the indicated times (min).
    Mouse Monoclonal Cd19, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal cd19/product/fluidigm
    Average 93 stars, based on 1 article reviews
    mouse monoclonal cd19 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    92
    fluidigm cat 3141003a rrid ab 2687639 142nd cd19 hib 19 standard biotools cat 3142001b rrid ab 3661857 143nd cd123
    a , b , Defective B cell maturation in the BM of individuals with CBL -LOH. Flow cytometry staining of cryopreserved BM mononuclear cells of HDs and participants P1, P2 and P3 with CBL -LOH. a , Representative flow staining of CD20 versus CD10 expression levels on CD34 − <t>CD19</t> + cells in BM samples. b , Quantification of these subsets for HDs ( n = 8), individuals with CBL -LOH ( n = 3) and individuals with PIK3CD GOF ( n = 3). The line shows the mean of the data points. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; * P < 0.05. c , d , In vitro differentiation of control AAVS1 -edited and CBL -edited CD34 + HSPCs toward B cell identity. c , Flow cytometry staining for CD10 and CD20 among CD19 + cells in differentiation cultures after 3 weeks of coculture. d , Quantification of B cell ‘subsets’ based on flow cytometry marker expression (pre-BI, CD10 + CD20 − ; pre-BII, CD10 + CD20 + ; immature B, CD10 + CD20 ++ ; mature B, CD10 − CD20 ++ ) in this culture in control and two CBL -edited reactions. The lines show the means of three biological replicates, except for AAVS1 single guide RNA (sgRNA) 1, where two replicates are shown. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; ** P < 0.005. e , Transcriptional overlap between CBL -edited and PI3K GOF HSPC-derived B cell progenitors. Gene set enrichment analysis for PI3K GOF gene signatures in CBL Ub LOF samples is shown; NES, normalized enrichment score. No correction for multiple testing was performed for the two binomial tests. f , Quantitative genotyping by amplicon sequencing of B cell subsets and monocytes in individuals with CBL -LOH and HDs, as well as parents of P1–P3; HDs ( n = 3), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. g , CD38 staining intensity of primary B cell subsets of pediatric individuals with CBL -LOH compared with age-matched HDs; HDs ( n = 9), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. The statistical significance of differences was assessed by multiple two-sided Mann–Whitney tests, with correction for multiple testing; * P < 0.05. h , Rate of apoptosis following stimulation with daratumumab of CD19 + cells from in vitro differentiation cultures of control and CBL -edited HSPCs. Data show the mean of three technical replicates. The experiment is representative of three biological replicates. i , Rate of apoptosis following stimulation with daratumumab of control and CBL Y371C KI REH cells. Each dot represents one biological replicate; n = 7. The statistical significance of differences was assessed using multiple paired, two-sided t- tests, with correction for multiple testing. j , Western blot of control and CBL Y371C KI REH cells following stimulation with monoclonal anti-CD38 (daratumumab) for the indicated times (min).
    Cat 3141003a Rrid Ab 2687639 142nd Cd19 Hib 19 Standard Biotools Cat 3142001b Rrid Ab 3661857 143nd Cd123, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cat 3141003a rrid ab 2687639 142nd cd19 hib 19 standard biotools cat 3142001b rrid ab 3661857 143nd cd123/product/fluidigm
    Average 92 stars, based on 1 article reviews
    cat 3141003a rrid ab 2687639 142nd cd19 hib 19 standard biotools cat 3142001b rrid ab 3661857 143nd cd123 - by Bioz Stars, 2026-05
    92/100 stars
      Buy from Supplier

    93
    fluidigm 142nd cd19 hib 19
    a , b , Defective B cell maturation in the BM of individuals with CBL -LOH. Flow cytometry staining of cryopreserved BM mononuclear cells of HDs and participants P1, P2 and P3 with CBL -LOH. a , Representative flow staining of CD20 versus CD10 expression levels on CD34 − <t>CD19</t> + cells in BM samples. b , Quantification of these subsets for HDs ( n = 8), individuals with CBL -LOH ( n = 3) and individuals with PIK3CD GOF ( n = 3). The line shows the mean of the data points. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; * P < 0.05. c , d , In vitro differentiation of control AAVS1 -edited and CBL -edited CD34 + HSPCs toward B cell identity. c , Flow cytometry staining for CD10 and CD20 among CD19 + cells in differentiation cultures after 3 weeks of coculture. d , Quantification of B cell ‘subsets’ based on flow cytometry marker expression (pre-BI, CD10 + CD20 − ; pre-BII, CD10 + CD20 + ; immature B, CD10 + CD20 ++ ; mature B, CD10 − CD20 ++ ) in this culture in control and two CBL -edited reactions. The lines show the means of three biological replicates, except for AAVS1 single guide RNA (sgRNA) 1, where two replicates are shown. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; ** P < 0.005. e , Transcriptional overlap between CBL -edited and PI3K GOF HSPC-derived B cell progenitors. Gene set enrichment analysis for PI3K GOF gene signatures in CBL Ub LOF samples is shown; NES, normalized enrichment score. No correction for multiple testing was performed for the two binomial tests. f , Quantitative genotyping by amplicon sequencing of B cell subsets and monocytes in individuals with CBL -LOH and HDs, as well as parents of P1–P3; HDs ( n = 3), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. g , CD38 staining intensity of primary B cell subsets of pediatric individuals with CBL -LOH compared with age-matched HDs; HDs ( n = 9), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. The statistical significance of differences was assessed by multiple two-sided Mann–Whitney tests, with correction for multiple testing; * P < 0.05. h , Rate of apoptosis following stimulation with daratumumab of CD19 + cells from in vitro differentiation cultures of control and CBL -edited HSPCs. Data show the mean of three technical replicates. The experiment is representative of three biological replicates. i , Rate of apoptosis following stimulation with daratumumab of control and CBL Y371C KI REH cells. Each dot represents one biological replicate; n = 7. The statistical significance of differences was assessed using multiple paired, two-sided t- tests, with correction for multiple testing. j , Western blot of control and CBL Y371C KI REH cells following stimulation with monoclonal anti-CD38 (daratumumab) for the indicated times (min).
    142nd Cd19 Hib 19, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/142nd cd19 hib 19/product/fluidigm
    Average 93 stars, based on 1 article reviews
    142nd cd19 hib 19 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    a , b , Defective B cell maturation in the BM of individuals with CBL -LOH. Flow cytometry staining of cryopreserved BM mononuclear cells of HDs and participants P1, P2 and P3 with CBL -LOH. a , Representative flow staining of CD20 versus CD10 expression levels on CD34 − CD19 + cells in BM samples. b , Quantification of these subsets for HDs ( n = 8), individuals with CBL -LOH ( n = 3) and individuals with PIK3CD GOF ( n = 3). The line shows the mean of the data points. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; * P < 0.05. c , d , In vitro differentiation of control AAVS1 -edited and CBL -edited CD34 + HSPCs toward B cell identity. c , Flow cytometry staining for CD10 and CD20 among CD19 + cells in differentiation cultures after 3 weeks of coculture. d , Quantification of B cell ‘subsets’ based on flow cytometry marker expression (pre-BI, CD10 + CD20 − ; pre-BII, CD10 + CD20 + ; immature B, CD10 + CD20 ++ ; mature B, CD10 − CD20 ++ ) in this culture in control and two CBL -edited reactions. The lines show the means of three biological replicates, except for AAVS1 single guide RNA (sgRNA) 1, where two replicates are shown. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; ** P < 0.005. e , Transcriptional overlap between CBL -edited and PI3K GOF HSPC-derived B cell progenitors. Gene set enrichment analysis for PI3K GOF gene signatures in CBL Ub LOF samples is shown; NES, normalized enrichment score. No correction for multiple testing was performed for the two binomial tests. f , Quantitative genotyping by amplicon sequencing of B cell subsets and monocytes in individuals with CBL -LOH and HDs, as well as parents of P1–P3; HDs ( n = 3), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. g , CD38 staining intensity of primary B cell subsets of pediatric individuals with CBL -LOH compared with age-matched HDs; HDs ( n = 9), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. The statistical significance of differences was assessed by multiple two-sided Mann–Whitney tests, with correction for multiple testing; * P < 0.05. h , Rate of apoptosis following stimulation with daratumumab of CD19 + cells from in vitro differentiation cultures of control and CBL -edited HSPCs. Data show the mean of three technical replicates. The experiment is representative of three biological replicates. i , Rate of apoptosis following stimulation with daratumumab of control and CBL Y371C KI REH cells. Each dot represents one biological replicate; n = 7. The statistical significance of differences was assessed using multiple paired, two-sided t- tests, with correction for multiple testing. j , Western blot of control and CBL Y371C KI REH cells following stimulation with monoclonal anti-CD38 (daratumumab) for the indicated times (min).

    Journal: Nature Immunology

    Article Title: Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function

    doi: 10.1038/s41590-025-02381-7

    Figure Lengend Snippet: a , b , Defective B cell maturation in the BM of individuals with CBL -LOH. Flow cytometry staining of cryopreserved BM mononuclear cells of HDs and participants P1, P2 and P3 with CBL -LOH. a , Representative flow staining of CD20 versus CD10 expression levels on CD34 − CD19 + cells in BM samples. b , Quantification of these subsets for HDs ( n = 8), individuals with CBL -LOH ( n = 3) and individuals with PIK3CD GOF ( n = 3). The line shows the mean of the data points. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; * P < 0.05. c , d , In vitro differentiation of control AAVS1 -edited and CBL -edited CD34 + HSPCs toward B cell identity. c , Flow cytometry staining for CD10 and CD20 among CD19 + cells in differentiation cultures after 3 weeks of coculture. d , Quantification of B cell ‘subsets’ based on flow cytometry marker expression (pre-BI, CD10 + CD20 − ; pre-BII, CD10 + CD20 + ; immature B, CD10 + CD20 ++ ; mature B, CD10 − CD20 ++ ) in this culture in control and two CBL -edited reactions. The lines show the means of three biological replicates, except for AAVS1 single guide RNA (sgRNA) 1, where two replicates are shown. Statistical significance was assessed using multiple two-sided Mann–Whitney tests corrected for multiple testing; ** P < 0.005. e , Transcriptional overlap between CBL -edited and PI3K GOF HSPC-derived B cell progenitors. Gene set enrichment analysis for PI3K GOF gene signatures in CBL Ub LOF samples is shown; NES, normalized enrichment score. No correction for multiple testing was performed for the two binomial tests. f , Quantitative genotyping by amplicon sequencing of B cell subsets and monocytes in individuals with CBL -LOH and HDs, as well as parents of P1–P3; HDs ( n = 3), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. g , CD38 staining intensity of primary B cell subsets of pediatric individuals with CBL -LOH compared with age-matched HDs; HDs ( n = 9), individuals with CBL -LOH ( n = 5). Data are shown as mean ± s.d. The statistical significance of differences was assessed by multiple two-sided Mann–Whitney tests, with correction for multiple testing; * P < 0.05. h , Rate of apoptosis following stimulation with daratumumab of CD19 + cells from in vitro differentiation cultures of control and CBL -edited HSPCs. Data show the mean of three technical replicates. The experiment is representative of three biological replicates. i , Rate of apoptosis following stimulation with daratumumab of control and CBL Y371C KI REH cells. Each dot represents one biological replicate; n = 7. The statistical significance of differences was assessed using multiple paired, two-sided t- tests, with correction for multiple testing. j , Western blot of control and CBL Y371C KI REH cells following stimulation with monoclonal anti-CD38 (daratumumab) for the indicated times (min).

    Article Snippet: 142Nd , CD19 , HIB19 , 3142001B , Fluidigm.

    Techniques: Flow Cytometry, Staining, Expressing, MANN-WHITNEY, In Vitro, Control, Marker, Derivative Assay, Amplification, Sequencing, Western Blot

    ( a ) Levels of sCD40L, APRIL and BAFF in the plasma of CBL-LOH patients (n = 6) and healthy donors (n = 14). Line shows the mean of the displayed datapoints (one point per individual assessed). ( b ) Quantification of the production of sCD40L, APRIL and BAFF by PBMCs of CBL-LOH patients (n = 3) and healthy donors (n = 5). Line shows the mean of the displayed datapoints (one point per individual assessed). ( c-f ) Impact of sCD40L levels on B cell differentiation in vitro using CD34+ HSPCs. ( c,d ) B cell output at day 21 of co-culture of CD34+ HSPCs from two healthy donors. The MS5 co-culture was supplement with IL-7 (20 ng/mL) and the indicated doses of sCD40L. Mean of dots that represent technical replicates. ( e,f ) Quantification of B cell subsets based on CD10 and CD20 marker expression. Cells were treated as in ( c,d ). Mean ± s.d. ( g ) IL-21 production by sorted CD4 + naïve and memory T cells upon the indicated stimuli. Mean ± s.d. ( h ) Surface staining of CD38 expressed on CD19+ HSPC-derived B cell progenitors edited with the indicated sgRNAs. Mean ± s.d. of three biological replicates. ( i ) Surface staining of CD38 expressed on HEK293T, REH and BJAB cells as determined by flow cytometry. Mean ± s.d. of three biological replicates. ( j ) CBL Y371C KI BJAB (n = 9) cells are not more resistant than WT (n = 5) cells to BCR-induced apoptosis. Mean ± s.d. of clones over three independent experiments.

    Journal: Nature Immunology

    Article Title: Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function

    doi: 10.1038/s41590-025-02381-7

    Figure Lengend Snippet: ( a ) Levels of sCD40L, APRIL and BAFF in the plasma of CBL-LOH patients (n = 6) and healthy donors (n = 14). Line shows the mean of the displayed datapoints (one point per individual assessed). ( b ) Quantification of the production of sCD40L, APRIL and BAFF by PBMCs of CBL-LOH patients (n = 3) and healthy donors (n = 5). Line shows the mean of the displayed datapoints (one point per individual assessed). ( c-f ) Impact of sCD40L levels on B cell differentiation in vitro using CD34+ HSPCs. ( c,d ) B cell output at day 21 of co-culture of CD34+ HSPCs from two healthy donors. The MS5 co-culture was supplement with IL-7 (20 ng/mL) and the indicated doses of sCD40L. Mean of dots that represent technical replicates. ( e,f ) Quantification of B cell subsets based on CD10 and CD20 marker expression. Cells were treated as in ( c,d ). Mean ± s.d. ( g ) IL-21 production by sorted CD4 + naïve and memory T cells upon the indicated stimuli. Mean ± s.d. ( h ) Surface staining of CD38 expressed on CD19+ HSPC-derived B cell progenitors edited with the indicated sgRNAs. Mean ± s.d. of three biological replicates. ( i ) Surface staining of CD38 expressed on HEK293T, REH and BJAB cells as determined by flow cytometry. Mean ± s.d. of three biological replicates. ( j ) CBL Y371C KI BJAB (n = 9) cells are not more resistant than WT (n = 5) cells to BCR-induced apoptosis. Mean ± s.d. of clones over three independent experiments.

    Article Snippet: 142Nd , CD19 , HIB19 , 3142001B , Fluidigm.

    Techniques: Clinical Proteomics, Cell Differentiation, In Vitro, Co-Culture Assay, Marker, Expressing, Staining, Derivative Assay, Flow Cytometry, Clone Assay

    ( a-f ) Western blots of wildtype and CBL Y371C KI REH cells upon CD38 crosslinking with daratumumab for the indicated time periods (min/h). ( b,c, e,f ) Shows quantifications of three biological replicates. Mean ± s.d. Statistical significance was assessed with Mann Whitney tests. *p<0.05. ( g,h ) ERK phosphorylation upon CD38 crosslinking in gene-edited HSPC-derived CD19+ B progenitors. Total CD19+ ( g ) or CD19+CD20high ( h ) B progenitors were sorted from co-cultures edited at the AAVS1 or CBL locus. Cells were stimulated for 15 min with daratumumab, followed by fixation, permeabilization and intracellular staining for phosphorylated ERK (pERK). n = 2 biological replicates. Bars show the mean.

    Journal: Nature Immunology

    Article Title: Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function

    doi: 10.1038/s41590-025-02381-7

    Figure Lengend Snippet: ( a-f ) Western blots of wildtype and CBL Y371C KI REH cells upon CD38 crosslinking with daratumumab for the indicated time periods (min/h). ( b,c, e,f ) Shows quantifications of three biological replicates. Mean ± s.d. Statistical significance was assessed with Mann Whitney tests. *p<0.05. ( g,h ) ERK phosphorylation upon CD38 crosslinking in gene-edited HSPC-derived CD19+ B progenitors. Total CD19+ ( g ) or CD19+CD20high ( h ) B progenitors were sorted from co-cultures edited at the AAVS1 or CBL locus. Cells were stimulated for 15 min with daratumumab, followed by fixation, permeabilization and intracellular staining for phosphorylated ERK (pERK). n = 2 biological replicates. Bars show the mean.

    Article Snippet: 142Nd , CD19 , HIB19 , 3142001B , Fluidigm.

    Techniques: Western Blot, MANN-WHITNEY, Phospho-proteomics, Derivative Assay, Staining